Money Concepts Capital Corp cut its position in Humana Inc. (NYSE:HUM - Free Report) by 48.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,437 shares of the insurance provider's stock after selling 1,344 shares during the quarter. Money Concepts Capital Corp's holdings in Humana were worth $380,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also bought and sold shares of HUM. Dodge & Cox grew its stake in Humana by 106.7% in the 4th quarter. Dodge & Cox now owns 10,198,040 shares of the insurance provider's stock valued at $2,587,345,000 after buying an additional 5,264,045 shares during the last quarter. Vanguard Group Inc. grew its stake in Humana by 15.8% in the 4th quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider's stock valued at $3,254,899,000 after buying an additional 1,751,857 shares during the last quarter. Norges Bank acquired a new position in Humana in the 4th quarter valued at $416,202,000. Pzena Investment Management LLC grew its stake in Humana by 44.0% in the 4th quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock valued at $915,736,000 after buying an additional 1,103,132 shares during the last quarter. Finally, Boston Partners grew its stake in Humana by 435.8% in the 4th quarter. Boston Partners now owns 1,098,702 shares of the insurance provider's stock valued at $279,236,000 after buying an additional 893,637 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of research analysts recently issued reports on HUM shares. Barclays set a $268.00 target price on shares of Humana and gave the company an "equal weight" rating in a research note on Thursday, June 12th. Mizuho increased their price target on shares of Humana from $305.00 to $316.00 and gave the company an "outperform" rating in a report on Wednesday, April 9th. Truist Financial set a $280.00 price target on shares of Humana and gave the company a "hold" rating in a report on Tuesday, June 17th. Guggenheim initiated coverage on shares of Humana in a report on Wednesday, April 9th. They issued a "buy" rating and a $326.00 price target for the company. Finally, Wall Street Zen raised shares of Humana from a "hold" rating to a "buy" rating in a report on Friday. Sixteen equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $280.76.
Check Out Our Latest Research Report on HUM
Humana Price Performance
NYSE:HUM opened at $241.82 on Friday. Humana Inc. has a 52 week low of $212.45 and a 52 week high of $406.46. The company has a market capitalization of $29.18 billion, a price-to-earnings ratio of 17.10, a PEG ratio of 1.82 and a beta of 0.43. The company has a 50-day moving average of $241.94 and a 200-day moving average of $259.30. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.91 and a current ratio of 1.91.
Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.07 by $1.51. Humana had a net margin of 1.42% and a return on equity of 14.47%. The firm had revenue of $32.11 billion during the quarter, compared to the consensus estimate of $32 billion. During the same period last year, the firm posted $7.23 EPS. The firm's quarterly revenue was up 8.4% on a year-over-year basis. As a group, equities research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current fiscal year.
Humana Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.46%. The ex-dividend date is Friday, June 27th. Humana's dividend payout ratio is currently 25.04%.
About Humana
(
Free Report)
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.